P.530 Disseminated cryptococcosis and histoplasmosis in a renal transplant recipient
Dr. Abhishek Suhas Borle, India
P.531 Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients: Diagnostic test accuracy review
Please note there have been some changes since the abstract submission - Thank you
Dr. Thida Maung Myint, Australia
P.532 Advanced Kaposi Sarcoma With Extensive Pulmonary Involvement After Kidney
Transplantation
Dr. Walaa Dabbas, United States
P.533 A prospective randomised study from Eastern India comparing Basiliximab versus no induction immunosuppression in low immunological risk kidney transplant recipients
Dr. Varun Gosain, India
P.535 One year outcome of Anti-T-Lymphocyte Globulin (ATLG) Induction Therapy in Kidney Transplantation: A Single-Center Retrospective Analysis
Dr. Kamal Kiran Mukkavilli, India
P.534 Comparison of anti-human T-Lymphocyte immunoglobulin (r-ATLG - Grafalon) vs anti-thymocyte globulin (r-ATG - Thymoglobulin) in kidney transplant: A 5-year follow-up study
Dr. Vijay Kumar Sinha, India
P.536 The efficacy of Anti T-Lymphocyte Globulin as Induction Therapy in Kidney Transplantation: A Single-Center Retrospective Analysis
Dr. Piyali Sarkar, India
P.537 Atypical Hemolytic Uremic Syndrome: A Case Report Of 41 Year Old Female
Dr. Piyali Sarkar, India
P.540 Immunosuppressant-induced changes in gut microbiota cause loss of skeletal muscle mass
Dr. Mitsuru Tomizawa, Japan
P.542 Long-term clinical outcomes of late conversion to once-daily tacrolimus and sirolimus combination in stable kidney transplant recipients